• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 144 filed by Teladoc Health Inc.

    9/2/25 4:09:36 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care
    Get the next $TDOC alert in real time by email
    Form 144 Filer Information UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Form 144

    NOTICE OF PROPOSED SALE OF SECURITIES
    PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933

    FORM 144

    144: Filer Information

    Filer CIK
    0002037711
    Filer CCC
    XXXXXXXX
    Is this a LIVE or TEST Filing? Radio button checked LIVE Radio button not checked TEST

    Submission Contact Information

    Name
    Phone
    E-Mail Address

    144: Issuer Information

    Name of Issuer
    Teladoc Health, Inc.
    SEC File Number
    001-37477
    Address of Issuer
    155 E 44TH STREET
    FLOOR 17
    NEW YORK
    NEW YORK
    10017
    Phone
    2036352002
    Name of Person for Whose Account the Securities are To Be Sold
    Nueno Carlos
    See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

    Relationship to Issuer
    Officer

    144: Securities Information

    Title of the Class of Securities To Be SoldName and Address of the BrokerNumber of Shares or Other Units To Be SoldAggregate Market ValueNumber of Shares or Other Units OutstandingApproximate Date of SaleName the Securities Exchange
    Common
    Fidelity Brokerage Services LLC
    900 Salem Street
    Smithfield � RI � 02917
    399830326.0317669066209/02/2025
    NYSE


    Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

    144: Securities To Be Sold

    Title of the ClassDate you AcquiredNature of Acquisition TransactionName of Person from Whom AcquiredIs this a Gift?Date Donor AcquiredAmount of Securities AcquiredDate of PaymentNature of Payment *
    Common08/29/2025Restricted Stock VestingIssuerCheckbox not checked399808/29/2025Compensation

    * If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



    Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

    144: Securities Sold During The Past 3 Months

    Name and Address of SellerTitle of Securities SoldDate of SaleAmount of Securities SoldGross Proceeds
    Carlos Nueno
    155 E 44th Street, Floor 17
    New York � NY � 10017
    Common06/02/2025395827151.88

    144: Remarks and Signature

    Remarks
    Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
    Date of Notice
    09/02/2025

    ATTENTION:

    The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
    Signature
    /s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Carlos Nueno Plana

    ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

    Get the next $TDOC alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $TDOC

    DatePrice TargetRatingAnalyst
    7/25/2025$10.00Neutral
    Mizuho
    11/15/2024$14.00Buy
    Goldman
    9/17/2024$8.00 → $10.00Hold
    Jefferies
    2/29/2024$22.00Overweight
    Cantor Fitzgerald
    2/26/2024$17.00Market Perform
    Leerink Partners
    1/17/2024$33.00 → $22.00Buy → Neutral
    DA Davidson
    1/3/2024$26.00Overweight
    Barclays
    4/12/2023$25.00Equal-Weight
    Stephens
    More analyst ratings

    $TDOC
    SEC Filings

    View All

    Teladoc Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Teladoc Health, Inc. (0001477449) (Filer)

    10/23/25 4:07:40 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    SEC Form 144 filed by Teladoc Health Inc.

    144 - Teladoc Health, Inc. (0001477449) (Subject)

    9/11/25 3:28:57 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    SEC Form 144 filed by Teladoc Health Inc.

    144 - Teladoc Health, Inc. (0001477449) (Subject)

    9/2/25 4:09:36 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    $TDOC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Mckinley Thomas bought $30,756 worth of shares (4,000 units at $7.69), increasing direct ownership by 11% to 39,077 units (SEC Form 4)

    4 - Teladoc Health, Inc. (0001477449) (Issuer)

    9/13/24 5:14:02 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    Director Smith Mark Douglas bought $28,312 worth of shares (4,000 units at $7.08), increasing direct ownership by 92% to 8,355 units (SEC Form 4)

    4 - Teladoc Health, Inc. (0001477449) (Issuer)

    8/19/24 4:10:41 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    Director Mckinley Thomas bought $81,746 worth of shares (11,000 units at $7.43), increasing direct ownership by 46% to 35,077 units (SEC Form 4)

    4 - Teladoc Health, Inc. (0001477449) (Issuer)

    8/8/24 5:49:44 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    $TDOC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    AR/VR is Revolutionizing Medical Education & Training While Transforming Healthcare Industry

    NEW YORK, Oct. 28, 2025 (GLOBE NEWSWIRE) -- MarketNewsUpdates News Commentary A recent report from ResearchAndMarkets said that the U.S. augmented reality and virtual reality in healthcare market size which was estimated at USD 1.03 billion in 2024 is projected to grow at a CAGR of 15.4% from 2025 to 2030. It said that advancements in healthcare IT infrastructure and increased venture capital investment, fueled by numerous start-ups and government programs such as NIH and FDA initiatives, support AR/VR research. In addition, the declining cost of head-mounted devices, rising demand from telemedicine, chronic disease care, and minimally invasive surgery, and integration with AI and 5G tech

    10/28/25 9:00:00 AM ET
    $GPRO
    $QCOM
    $TDOC
    Industrial Machinery/Components
    Consumer Discretionary
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Teladoc Health Announces Chief Financial Officer Transition

    NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE:TDOC), the global leader in virtual care, today announced that Mala Murthy will be stepping down from her role as Chief Financial Officer to pursue an opportunity outside of the healthcare industry. Ms. Murthy will continue to serve in her role until her departure on November 21, 2025 and will present on the company's third quarter earnings conference call. The company has initiated a search process to identify its next CFO. To ensure a seamless transition while the search is completed, an interim leadership structure will be in place with key finance leaders reporting to Teladoc Health Chief Executive Officer Chuck Divita.

    10/23/25 4:05:00 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    Teladoc Health to Announce Third Quarter 2025 Financial Results

    NEW YORK, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE:TDOC), the global leader in virtual care, announced that it will release third quarter 2025 results on Wednesday, October 29, 2025, after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. ET on the same day.  Conference Call Details The conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 609817. For international participants, please visit the following link for global dial-in numbers: https://www.netroadshow.com/conferencing/global-numbers?confId=90432. A live audio webcast will also be available online at ht

    10/15/25 4:30:22 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    $TDOC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Accounting Officer Catapano Joseph Ronald converted options into 8,333 shares and sold $23,434 worth of shares (2,972 units at $7.89) (SEC Form 4)

    4 - Teladoc Health, Inc. (0001477449) (Issuer)

    10/3/25 4:05:34 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    Director Evans Jason Eric converted options into 1,016 shares, increasing direct ownership by 14% to 8,129 units (SEC Form 4)

    4 - Teladoc Health, Inc. (0001477449) (Issuer)

    9/22/25 4:14:09 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    CHIEF EXECUTIVE OFFICER Divita Charles Iii converted options into 39,160 shares and sold $127,435 worth of shares (16,787 units at $7.59), increasing direct ownership by 14% to 179,014 units (SEC Form 4)

    4 - Teladoc Health, Inc. (0001477449) (Issuer)

    9/11/25 4:04:10 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    $TDOC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Mizuho initiated coverage on Teladoc with a new price target

    Mizuho initiated coverage of Teladoc with a rating of Neutral and set a new price target of $10.00

    7/25/25 9:07:34 AM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    Goldman initiated coverage on Teladoc with a new price target

    Goldman initiated coverage of Teladoc with a rating of Buy and set a new price target of $14.00

    11/15/24 8:22:14 AM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    Jefferies reiterated coverage on Teladoc with a new price target

    Jefferies reiterated coverage of Teladoc with a rating of Hold and set a new price target of $10.00 from $8.00 previously

    9/17/24 8:21:59 AM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    $TDOC
    Leadership Updates

    Live Leadership Updates

    View All

    AR/VR is Revolutionizing Medical Education & Training While Transforming Healthcare Industry

    NEW YORK, Oct. 28, 2025 (GLOBE NEWSWIRE) -- MarketNewsUpdates News Commentary A recent report from ResearchAndMarkets said that the U.S. augmented reality and virtual reality in healthcare market size which was estimated at USD 1.03 billion in 2024 is projected to grow at a CAGR of 15.4% from 2025 to 2030. It said that advancements in healthcare IT infrastructure and increased venture capital investment, fueled by numerous start-ups and government programs such as NIH and FDA initiatives, support AR/VR research. In addition, the declining cost of head-mounted devices, rising demand from telemedicine, chronic disease care, and minimally invasive surgery, and integration with AI and 5G tech

    10/28/25 9:00:00 AM ET
    $GPRO
    $QCOM
    $TDOC
    Industrial Machinery/Components
    Consumer Discretionary
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Teladoc Health Board of Directors Announces Leadership Transition

    Jason Gorevic to depart the company, effective immediatelyCFO Mala Murthy appointed acting chief executiveTeladoc Health reaffirms guidance PURCHASE, NY, April 05, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today announced that Jason Gorevic is departing the company, effective immediately. The Board of Directors has appointed Mala Murthy acting Chief Executive Officer while it searches for Mr. Gorevic's permanent successor. Ms. Murthy is a seasoned industry leader who has served as the Company's Chief Financial Officer since 2019, and she will continue serving in this role during this transition period. The Board has ret

    4/5/24 6:30:18 AM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    Teladoc Health Appoints Leading Healthcare and Hospitals Executive Eric Evans to Board of Directors

    PURCHASE, NY, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today appointed Eric Evans to the company's board of directors. Mr. Evans, currently chief executive officer and director of Brentwood, TN-based Surgery Partners, Inc. (NASDAQ:SGRY), is a recognized healthcare and hospital executive with significant experience leading complex organizations operating at the intersection of care and technology. Mr. Evans joins the board following the retirement of Senator William Frist, M.D. earlier this year, and will serve on the board's compensation committee. David B. Snow, Jr., non-executive Chairman of the company's board,

    9/20/23 8:05:00 AM ET
    $SGRY
    $TDOC
    Hospital/Nursing Management
    Health Care
    Medical/Nursing Services

    $TDOC
    Financials

    Live finance-specific insights

    View All

    Teladoc Health Announces Chief Financial Officer Transition

    NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE:TDOC), the global leader in virtual care, today announced that Mala Murthy will be stepping down from her role as Chief Financial Officer to pursue an opportunity outside of the healthcare industry. Ms. Murthy will continue to serve in her role until her departure on November 21, 2025 and will present on the company's third quarter earnings conference call. The company has initiated a search process to identify its next CFO. To ensure a seamless transition while the search is completed, an interim leadership structure will be in place with key finance leaders reporting to Teladoc Health Chief Executive Officer Chuck Divita.

    10/23/25 4:05:00 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    Teladoc Health to Announce Third Quarter 2025 Financial Results

    NEW YORK, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE:TDOC), the global leader in virtual care, announced that it will release third quarter 2025 results on Wednesday, October 29, 2025, after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. ET on the same day.  Conference Call Details The conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 609817. For international participants, please visit the following link for global dial-in numbers: https://www.netroadshow.com/conferencing/global-numbers?confId=90432. A live audio webcast will also be available online at ht

    10/15/25 4:30:22 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    Teladoc Health Acquires Telecare, Expanding Access to Specialist and Allied Health Care for Australians in Public and Private Health

    MELBOURNE, Australia, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE:TDOC), the global leader in virtual care, today announced it has acquired Telecare, an innovative, Australian tech-enabled provider of specialist and allied health care via virtual delivery. Telecare operates Australia's leading virtual care clinic and provides software solutions to the healthcare sector. With over 300 virtual specialists in over 30 specialties, supporting both GP-referred appointments as well as providing virtual care services to public hospitals across Australia, Telecare helps reduce patient wait times and increases access to speciality care in underserved areas. Teladoc Health is the global

    8/14/25 5:00:10 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    $TDOC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Teladoc Health Inc.

    SC 13G - Teladoc Health, Inc. (0001477449) (Subject)

    9/5/24 4:36:22 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by Teladoc Health Inc.

    SC 13G/A - Teladoc Health, Inc. (0001477449) (Subject)

    7/8/24 4:32:41 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G/A filed by Teladoc Health Inc. (Amendment)

    SC 13G/A - Teladoc Health, Inc. (0001477449) (Subject)

    2/13/24 5:16:08 PM ET
    $TDOC
    Medical/Nursing Services
    Health Care